InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Brady Stewart
15 Aug 2025
Director
Buy
30,000
$6.82
$204.49K
Albert G White III
9 Jun 2025
Director
Buy
20,000
$9.45
$189.00K
Vikram Malik
15 Aug 2023
Director
Buy
174,967
$7.41
$1.30M
Robert Hayman
12 Sep 2022
Director
Buy indirect
1,091
$10.78
$11.76K
Robert Hayman
9 Sep 2022
Director
Buy indirect
8,909
$10.35
$92.18K
Robert Hayman
7 Sep 2022
Director
Buy
4,967
$10.05
$49.92K
Peter C Farrell
6 Sep 2022
Director
Buy indirect
10,000
$9.10
$91.05K
Simone Blank
6 Sep 2022
Director
Buy
20,000
$9.24
$184.84K
Medytox Inc.
27 Aug 2021
10% owner
Buy
51,000
$10.93
$557.57K
Medytox Inc.
26 Aug 2021
10% owner
Buy
66,000
$11.02
$727.41K
Medytox Inc.
25 Aug 2021
10% owner
Buy
44,000
$11.12
$489.39K
Medytox Inc.
24 Aug 2021
10% owner
Buy
72,219
$11.17
$807.03K
Medytox Inc.
23 Aug 2021
10% owner
Buy
69,781
$11.03
$769.78K
Medytox Inc.
20 Aug 2021
10% owner
Buy
48,000
$10.56
$506.70K
Medytox Inc.
19 Aug 2021
10% owner
Buy
55,000
$10.51
$578.11K
Medytox Inc.
18 Aug 2021
10% owner
Buy
45,000
$10.54
$474.08K
Medytox Inc.
17 Aug 2021
10% owner
Buy
70,000
$10.69
$748.06K
Medytox Inc.
16 Aug 2021
10% owner
Buy
65,000
$11.34
$737.04K
Medytox Inc.
13 Aug 2021
10% owner
Buy
49,714
$10.98
$545.72K
Medytox Inc.
13 Aug 2021
10% owner
Buy indirect
14,043
$11.11
$156.06K
Medytox Inc.
12 Aug 2021
10% owner
Buy
39,126
$10.93
$427.71K
Medytox Inc.
12 Aug 2021
10% owner
Buy indirect
23,000
$10.99
$252.77K
Medytox Inc.
11 Aug 2021
10% owner
Buy
26,160
$10.77
$281.74K
David N Gill
13 Jun 2019
Director
Buy
2,000
$13.65
$27.30K
Vikram Malik
3 Jun 2019
Director
Buy indirect
1,298,701
$19.25
$25.00M
Kristine Romine
29 May 2019
Director
Buy indirect
2,090
$14.77
$30.86K
Simone Blank
20 May 2019
Director
Buy indirect
628,536
$19.25
$12.10M
Kristine Romine
20 May 2019
Director
Buy
40,562
$19.25
$780.82K
Vikram Malik
17 Dec 2018
Director
Buy
7,800
$13.04
$101.69K
Kristine Romine
17 Dec 2018
Director
Buy
5,000
$12.75
$63.75K
David N Gill
14 Dec 2018
Director
Buy
3,000
$12.77
$38.30K
Kristine Romine
14 Dec 2018
Director
Buy
11,000
$12.50
$137.45K
Kristine Romine
29 Nov 2018
Director
Buy
6,347
$14.00
$88.86K
Simone Blank
29 Nov 2018
Director
Buy indirect
295,024
$14.00
$4.13M
Michael M. Jafar
14 Sep 2018
Chief Marketing Officer
Buy
12,800
$20.83
$266.59K
Kristine Romine
22 Aug 2018
Director
Buy
10,000
$19.83
$198.27K
Vikram Malik
14 Jun 2018
Director
Buy
8,600
$28.88
$248.35K
Kristine Romine
8 Jun 2018
Director
Buy
2,000
$28.05
$56.10K
Kristine Romine
7 Jun 2018
Director
Buy indirect
200
$33.40
$6.68K
Bosun Hau
6 Jun 2018
Director
Buy
2,898
$34.94
$101.26K
Bosun Hau
4 Jun 2018
Director
Buy
7,142
$29.19
$208.47K
Kristine Romine
1 Jun 2018
Director
Buy
4,000
$25.74
$102.95K
Kristine Romine
31 May 2018
Director
Buy indirect
1,000
$24.40
$24.40K
Kristine Romine
31 May 2018
Director
Buy
2,000
$24.40
$48.80K
Show all 142 transactions →

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018